Ion Exchange recasts reporting into five businesses from April

Ion Exchange (India) Limited adopted five reportable businesses from 1 April 2026, splitting its former Engineering segment into three units, while Specialty Chemicals generated the highest consolidated segment revenue of Rs 484.26 crore in the half year ended 30 September 2026, according to its filing.

Why did Ion Exchange change its segment reporting?

Ion Exchange changed its segment reporting to support its stated repositioning as a technology-led water and environment solutions provider rather than a conventional engineering, procurement and construction, or EPC, company. Effective from 1 April 2026, it said the strategic objective was to focus on growth in Products, Chemicals, Services and Solutions.

Ion Exchange replaced the former Engineering segment with Treatment Solutions, Industrial Products and Lifecycle Services. It also renamed the former Chemicals segment as Specialty Chemicals, retained Consumer Products as a reportable business, and regrouped prior periods so that the half year ended 30 September 2025 and year ended 31 March 2026 are comparable with the new structure.

What are Ion Exchange's five reportable businesses?

Ion Exchange now reports Treatment Solutions, Industrial Products, Lifecycle Services, Specialty Chemicals and Consumer Products as its five operating segments. Treatment Solutions includes water and wastewater treatment and recycling, ultra-pure and high-purity water, desalination, zero-liquid discharge and other advanced solutions.

Industrial Products includes standard water-treatment products, institutional water-treatment products and membranes. The institutional water-treatment products business was previously included in Consumer Products and was moved into Industrial Products from 1 April 2026.

Lifecycle Services covers operation and maintenance, rehabilitation and modification, spares, services and consumables, and build-own-operate and build-own-operate-transfer arrangements. Specialty Chemicals comprises water-treatment and process chemicals and industrial, process and pharmaceutical resins, while Consumer Products includes home water solutions, community water-treatment solutions and wellness.

Which Ion Exchange businesses changed most in the first half?

Specialty Chemicals was Ion Exchange's largest consolidated revenue segment in the half year ended 30 September 2026, with revenue of Rs 484.26 crore, up from Rs 406.99 crore in the regrouped prior-year half. Treatment Solutions was second at Rs 359.65 crore, but its revenue fell from Rs 479.65 crore.

Industrial Products increased revenue by Rs 48.05 crore to Rs 241.13 crore, while Consumer Products rose by Rs 51.56 crore to Rs 212.90 crore. Lifecycle Services increased by Rs 9.27 crore to Rs 142.19 crore, meaning four of the five recast businesses reported higher first-half revenue than in the comparable 2025 period.

Treatment Solutions reported a segment loss of Rs 138.89 crore in the half year ended 30 September 2026, compared with a segment profit of Rs 4.57 crore a year earlier. Specialty Chemicals' segment result declined to Rs 44.75 crore from Rs 109.13 crore, even as its revenue increased by Rs 77.27 crore.

How do Ion Exchange's new segments compare by assets and liabilities?

Specialty Chemicals had the largest consolidated segment asset base at Rs 1,268.82 crore on 30 September 2026, ahead of Treatment Solutions at Rs 1,245.77 crore. A year earlier, Treatment Solutions held Rs 1,251.21 crore of assets and Specialty Chemicals held Rs 1,039.75 crore, so Specialty Chemicals' asset base increased by Rs 229.07 crore.

Treatment Solutions carried the largest segment liabilities, at Rs 912.40 crore on 30 September 2026, up from Rs 748.28 crore a year earlier. Specialty Chemicals had liabilities of Rs 749.37 crore, while Industrial Products reported Rs 236.57 crore; total consolidated assets were Rs 3,403.25 crore and total consolidated liabilities were Rs 2,156.73 crore.

Lifecycle Services reported Rs 160.11 crore of segment assets and Rs 53.15 crore of segment liabilities at 30 September 2026. Consumer Products had assets of Rs 127.92 crore and liabilities of Rs 88.74 crore, while unallocated assets and liabilities stood at Rs 219.89 crore and Rs 114.63 crore respectively.

What did Ion Exchange report for first-half consolidated profit and cash flow?

Ion Exchange reported a consolidated loss before tax of Rs 101.39 crore for the half year ended 30 September 2026, compared with a profit before tax of Rs 132.96 crore in the comparable prior-year half. Total segment results were a loss of Rs 64.46 crore, versus a profit of Rs 152.34 crore, before finance cost, unallocable expenditure and interest income.

Finance cost increased to Rs 18.37 crore from Rs 5.64 crore, while interest income declined to Rs 6.27 crore from Rs 12.51 crore. Other unallocable expenditure, net of unallocable income, was Rs 24.83 crore, compared with Rs 26.25 crore in the half year ended 30 September 2025.

Ion Exchange generated Rs 39.76 crore of operating cash flow in the 2026 half year, compared with cash used in operations of Rs 8.26 crore a year earlier. Investing activities used Rs 53.46 crore and financing activities used Rs 50.93 crore, reducing cash and cash equivalents to Rs 115.33 crore on 30 September 2026 from Rs 184.56 crore at the start of the financial year.

Conclusion

Ion Exchange's new presentation separates solutions delivery, industrial products and lifecycle activity from the former Engineering segment, alongside Specialty Chemicals and Consumer Products. In the first half of 2026-27, the recast data showed consolidated segment revenue of Rs 1,440.13 crore, with Specialty Chemicals the largest contributor and Treatment Solutions reporting both lower revenue and a segment loss.

The next disclosures should show whether Ion Exchange's stated focus on Products, Chemicals, Services and Solutions changes the relative revenue and segment-result trends of the three businesses created from Engineering. The company disclosed the 1 April 2026 effective date and prior-period regrouping, but did not provide a numerical growth target or timetable for the repositioning.